However, in ALL patients, there was no significant relationship between the soluble level of syndecan-1 or its expression on leukocytes and the response to treatment (p = 1, p = 0.33; Table 4 and Figure 1). Here, SDC1 is linked to acute lymphoblastic leukemia.